newsfilter
← Latest News
GlobeNewswire·

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at